Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated
AD816 Crossover StudyNCT05793684ApnimedPhase 2Completed2023-11-09Actual
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisNCT05796765MDXGPhase 2Terminated2023-12-15Actual
Safety and Efficacy of VDMN-21 Patch in Subjects With Common WartsNCT05799157MANEPhase 2Completed2025-02-25Actual
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)NCT05811247ApnimedPhase 3Completed2025-05-07Actual
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)NCT05813275ApnimedPhase 3Completed2025-03-10Actual
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)NCT05814757OCULPhase 2Completed2024-05-22Actual
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)NCT05818553Praxis Precision MedicinesPhase 2, Phase 3Active not recruiting2025-11-12Actual
Study of TP-04 in Participants With Papulopustular RosaceaNCT05838170TARSPhase 2Completed2023-11-13Actual
Study of ADI-PEG 20 Versus Placebo in Subjects With NASHNCT05842512Polaris GroupPhase 2Recruiting2027-12-31Estimated
Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy InfantsNCT05844423PCVXPhase 2Completed2025-08-25Actual
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerNCT05848011MacroGenicsPhase 2Completed2026-02-19Actual
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)NCT05854784Clinuvel Pharmaceuticals LimitedPhase 2Completed2023-12-28Actual
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMANCT05855083Omeros CorporationPhase 2Recruiting2025-12Estimated
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusNCT05856448LKFTPhase 2Completed2025-10-08Actual
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgANNCT05856760TVTXPhase 2Completed2024-10-14Actual
A Biomarker Study of ATH434 in Participants With MSANCT05864365Alterity TherapeuticsPhase 2Completed2025-02-26Actual
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1NCT05870748STROPhase 2, Phase 3Terminated2025-08-26Actual
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of AgeNCT05871970Protara TherapeuticsPhase 2Recruiting2026-12Estimated
Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA VaccinesNCT05875701NovavaxPhase 3Completed2023-11-11Actual
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabNCT05877963TGTXPhase 3Recruiting2027-01-21Estimated
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPNCT05883748IRONPhase 2, Phase 3Enrolling by invitation2028-06Estimated
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273MapLight TherapeuticsPhase 2Active not recruiting2027-11Estimated
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)NCT05892614ATYRPhase 2Recruiting2026-04Estimated
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).NCT05893537Cognition TherapeuticsPhase 2Terminated2025-03-04Actual
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670OculisPhase 2Completed2024-03-27Actual
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett SyndromeNCT05898620NGNEPhase 3Active not recruiting2029-12Estimated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsNCT05899608Summit TherapeuticsPhase 3Recruiting2028-12-31Estimated
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion SicknessNCT05903924Vanda PharmaceuticalsPhase 3Completed2024-04-06Actual
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVNCT05904470AVIRPhase 2Completed2024-12-09Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.